Resistance of cancer cells to CTL-mediated immunotherapy /

Saved in:
Bibliographic Details
Imprint:Cham : Springer, 2015.
Description:1 online resource (xiv, 353 pages) : illustrations (some color).
Language:English
Series:Resistance to targeted anti-cancer therapeutics, 2196-5501 ; volume 7
Resistance to targeted anti-cancer therapeutics ; volume 7.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/11094643
Hidden Bibliographic Details
Other authors / contributors:Bonavida, Benjamin, editor.
Chouaib, S. (Salem), editor.
ISBN:9783319178073
3319178075
3319178067
9783319178066
9783319178066
Digital file characteristics:text file PDF
Notes:Includes index.
Online resource; title from PDF title page (SpringerLink, viewed June 24, 2015).
Summary:This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy.
Other form:Printed edition: 9783319178066
Standard no.:10.1007/978-3-319-17807-3

MARC

LEADER 00000cam a2200000Ii 4500
001 11094643
005 20170630044731.3
006 m o d
007 cr cnu|||unuuu
008 150623s2015 sz a o 001 0 eng d
003 ICU
040 |a N$T  |b eng  |e rda  |e pn  |c N$T  |d GW5XE  |d N$T  |d IDEBK  |d YDXCP  |d EBLCP  |d AZU  |d OCLCF  |d CDX  |d COO  |d VLB  |d OCLCQ  |d KSU  |d IAS  |d JBG  |d IAO  |d ICN  |d IAD  |d SOI  |d ILO  |d LVT  |d VT2  |d Z5A  |d OCLCO  |d MERER  |d OCLCO 
019 |a 972066126  |a 985057289 
020 |a 9783319178073  |q (electronic bk.) 
020 |a 3319178075  |q (electronic bk.) 
020 |a 3319178067  |q (print) 
020 |a 9783319178066  |q (print) 
020 |z 9783319178066 
024 7 |a 10.1007/978-3-319-17807-3  |2 doi 
035 |a (OCoLC)911386398  |z (OCoLC)972066126  |z (OCoLC)985057289 
050 4 |a RC271.I45  |b R47 2015eb 
072 7 |a HEA  |x 039000  |2 bisacsh 
072 7 |a MED  |x 014000  |2 bisacsh 
072 7 |a MED  |x 022000  |2 bisacsh 
072 7 |a MED  |x 112000  |2 bisacsh 
072 7 |a MED  |x 045000  |2 bisacsh 
072 7 |a MJCL  |2 bicssc 
049 |a MAIN 
245 0 0 |a Resistance of cancer cells to CTL-mediated immunotherapy /  |c Benjamin Bonavida, Salem Chouaib, editors. 
264 1 |a Cham :  |b Springer,  |c 2015. 
300 |a 1 online resource (xiv, 353 pages) :  |b illustrations (some color). 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a computer  |b c  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/c 
338 |a online resource  |b cr  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/cr 
347 |a text file  |b PDF  |2 rda 
490 1 |a Resistance to targeted anti-cancer therapeutics,  |x 2196-5501 ;  |v volume 7 
500 |a Includes index. 
588 0 |a Online resource; title from PDF title page (SpringerLink, viewed June 24, 2015). 
520 |a This book, written by leading investigators, brings together the latest knowledge about key aspects of the most rapidly progressing fields of tumor escape and tumor resistance to CTL. Readers will benefit from a collection of outstanding surveys that cover some factors regulating resistance to CTL cytotoxicity, the influence of tumor microenvironment, and the resistance to death ligands, mediated apoptosis, and means to reverse resistance. This remarkable volume also emphasizes the future directions that may lead to the design of more innovative, refined, and integrative immunotherapies to target tumor plasticity and heterogeneity, and help to overcome the inherent limitations of current treatments. By providing a broad scope of innovative concepts in the burgeoning field of cancer biology and immunotherapy, this volume will be of exceptional interest and a valuable reference for scientists, clinicians, health professionals, and biopharmaceutical companies working in the field of cancer immunotherapy. 
650 0 |a Drug resistance in cancer cells.  |0 http://id.loc.gov/authorities/subjects/sh90005205 
650 0 |a Cancer  |x Immunotherapy.  |0 http://id.loc.gov/authorities/subjects/sh87002642 
650 7 |a HEALTH & FITNESS  |x Diseases  |x General.  |2 bisacsh 
650 7 |a MEDICAL  |x Clinical Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Diseases.  |2 bisacsh 
650 7 |a MEDICAL  |x Evidence-Based Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Internal Medicine.  |2 bisacsh 
650 7 |a Cancer  |x Immunotherapy.  |2 fast  |0 (OCoLC)fst00845386 
650 7 |a Drug resistance in cancer cells.  |2 fast  |0 (OCoLC)fst00898703 
650 2 |a Immunotherapy, Adoptive  |x contraindications. 
650 2 |a T-Lymphocytes, Cytotoxic  |x immunology. 
655 4 |a Electronic books. 
700 1 |a Bonavida, Benjamin,  |e editor.  |0 http://id.loc.gov/authorities/names/n85263154  |1 http://viaf.org/viaf/165364903 
700 1 |a Chouaib, S.  |q (Salem),  |e editor.  |0 http://id.loc.gov/authorities/names/n00123488  |1 http://viaf.org/viaf/29679278 
776 0 8 |i Printed edition:  |z 9783319178066 
830 0 |a Resistance to targeted anti-cancer therapeutics ;  |v volume 7. 
856 4 0 |u http://link.springer.com/10.1007/978-3-319-17807-3  |y SpringerLink 
903 |a HeVa 
929 |a eresource 
999 f f |i 4a0d8460-d9f3-5fe3-805a-09ca73b14e65  |s ae03ebe2-a72b-5417-875e-e60ce67dea18 
928 |t Library of Congress classification  |a RC271.I45 R47 2015eb  |l Online  |c UC-FullText  |u http://link.springer.com/10.1007/978-3-319-17807-3  |z SpringerLink  |g ebooks  |i 9908900